相关实验视频

Updated: Jun 25, 2025

The Lambda Select cII Mutation Detection System

The Lambda Select cII Mutation Detection System

Published on: April 26, 2018

一个模块化策略,用于测试和评估非遗传毒性致癌物

Kimmo Louekari¹, Miriam N Jacobs²

¹, Helsinki, Finland.

Archives of toxicology

|May 29, 2024

概括

一个新的模块化测试策略 (MoSt) 评估了用于监管的非遗传毒性致癌性 (NGTxC). 这种方法整合了多个测试水平,为化学安全评估提供了证据权重的结论.

科学领域:

毒理学毒理学毒理学
致癌的发生是致癌的产生.
监管科学监管科学

背景情况:

非遗传毒性致癌性 (NGTxC) 评估对于监管应用至关重要.
现有的方法需要整合,以进行全面的评估.
经合组织NGTxC专家组提供了基础工作.

研究的目的:

描述一种模块化策略,用于测试和评估 (MoSt) 非遗传毒性致癌性 (NGTxC).
确保该战略适用于监管应用,包括EU-REACH.
为代测试选择和证据权重结论提供一个框架.

主要方法:

从分子,细胞和组织层面整合测试方法.
一个由六个模块组成的渐进式策略,带有代测试选择指导.
证据权重的方法优先考虑与致癌相关的机械相关的发现.

主要成果:

介绍了NGTxC评估的结构化,模块化方法.
该战略结合了跨生物层面的多种测试方法.
为代测试选择和综合评估提供了指导.

结论:

该MoSt战略为NGTxC的监管评估提供了一个强大的框架.
它通过整合来自多个来源的数据来促进证据权重的结论.
该方法可以在等待验证的司法管辖区内适应监管目的.

关键词:

国际航空交通协会 (IATA) 的模块化战略是一个模块化战略.非基因毒性的致癌性监管框架监管框架监管框架

更多相关视频

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC

Published on: May 10, 2016

相关概念视频

Mutagenicity and Carcinogenicity

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...